Nu-Med Plus (NUMD) Operating Income (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.12% |
| Sep 30, 2025 | 3.30% |
| Jun 30, 2025 | 44.28% |
| Mar 31, 2025 | -101.21% |
| Dec 31, 2024 | 46.64% |
| Sep 30, 2024 | -8.58% |
| Jun 30, 2024 | 22.06% |
| Mar 31, 2024 | 62.81% |
| Dec 31, 2023 | -265.35% |
| Sep 30, 2023 | 34.36% |
| Jun 30, 2023 | 14.45% |
| Mar 31, 2023 | -321.82% |
| Dec 31, 2022 | 88.99% |
| Sep 30, 2022 | 0.03% |
| Jun 30, 2022 | 2.65% |
| Mar 31, 2022 | 46.90% |
| Dec 31, 2021 | 5.09% |
| Sep 30, 2021 | 53.03% |
| Jun 30, 2021 | 29.36% |
| Mar 31, 2021 | 29.42% |
| Dec 31, 2020 | -12.39% |
| Sep 30, 2020 | 50.49% |
| Jun 30, 2020 | -508.43% |
| Mar 31, 2020 | 27.41% |
| Dec 31, 2019 | -40.69% |
| Sep 30, 2019 | 40.02% |
| Jun 30, 2019 | 42.47% |
| Mar 31, 2019 | -19.23% |
| Dec 31, 2018 | 31.92% |
| Sep 30, 2018 | -209.44% |
| Jun 30, 2018 | -18.34% |
| Mar 31, 2018 | -103.66% |
| Dec 31, 2017 | 2,928.17% |
| Sep 30, 2017 | -23.76% |
| Jun 30, 2017 | -59.63% |
| Mar 31, 2017 | -107.42% |
| Dec 31, 2016 | 235.01% |
| Sep 30, 2016 | -290.99% |
| Jun 30, 2016 | -171.03% |
| Mar 31, 2016 | -108.09% |
| Dec 31, 2015 | 367.44% |
| Sep 30, 2015 | 22.07% |
| Jun 30, 2015 | -228.03% |
| Mar 31, 2015 | 77.60% |
| Dec 31, 2014 | -121.77% |
| Sep 30, 2014 | -20.49% |
| Jun 30, 2014 | -10.79% |
| Sep 30, 2013 | -158.78% |
| Jun 30, 2013 | 57.89% |
| Mar 31, 2013 | 69.25% |